SCHEMBL13243050

SCHEMBL13243050

Cc1c(N)[nH]c2cc(C#N)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITK Q08881 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ CSNK1A1 P48729 1/20 0.39
▸ CSNK1D P48730 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ CSNK1G2 P78368 1/20 0.39
▸ NOS3 P29474 1/20 0.39
▸ NOS1 P29475 1/20 0.39
▸ NOS2 P35228 1/20 0.39
▸ MAPK10 P53779 1/20 0.39
▸ RIPK1 Q13546 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ IDO1 P14902 1/20 0.37
▸ RET P07949 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ CHUK O15111 1/20 0.36
▸ USP20 Q9Y2K6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14022011 0.82 AHR (0.47) ITKALDH1A1CYP2A6CSNK1A1CSNK1D
SCHEMBL6007662 0.77 CHUK (0.53) ITKALDH1A1CYP2A6NOS3NOS1
SCHEMBL6008260 0.77 KIF11 (0.58) ITKALDH1A1CYP2A6CSNK1A1CSNK1D
SCHEMBL31025877 0.76 PIN1 (0.49) ALDH1A1L3MBTL1MEN1KMT2AALK
SCHEMBL15146065 0.74 PIN1 (0.41) NOS3NOS1NOS2MAPK10RIPK1
SCHEMBL6218634 0.74 PIN1 (0.48) NOS3NOS1NOS2MAPK10RIPK1
SCHEMBL29894052 0.74 KDM4E (0.59) ALDH1A1NOS3NOS1NOS2
SCHEMBL4736477 0.74 KDM4E (0.59) ALDH1A1NOS3NOS1NOS2
SCHEMBL3121078 0.73 ALOX15 (0.44) ALDH1A1MEN1KMT2AALK
SCHEMBL23885618 0.72 USP20 (0.51) ITKALDH1A1MEN1KMT2AUSP20

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100210639-A1 9H-PYRIMIDO[4,5-B]INDOLES, 9H-PYRIDO[4',3':4,5]PYRROLO[2,3-D]PYRIDINES, AND 9H 1,3,6,9 TETRAAZA-FLUORENES AS CHK1 KINASE FUNCTION INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2010-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210639-A1 9H-PYRIMIDO[4,5-B]INDOLES, 9H-PYRIDO[4',3':4,5]PYRROLO[2,3-D]PYRIDINES, AND 9H 1,3,6,9 TETRAAZA-FLUORENES AS CHK1 KINASE FUNCTION INHIBITORS CHEK1, CHEK2, PLK1 ITK 401/4885ALDH1A1 2087/4885CYP2A6 2931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback